Jasira Ziglar, MD
General Practice Physician in Springfield, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 16,838 in General Practice Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jasira Ziglar, MD filed 401 Medicare Part D claims in 2024 as a General Practice Physician in Springfield, Massachusetts, prescribing 65% generic.
- 401
- Part D claims, 2024
- 65%
- generic prescribing
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jasira Ziglar, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1952003030), first enumerated 03/21/2023.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 401 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Jasira Ziglar, MD's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1952003030 · General Practice Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1952003030
- ENUM-RECENT 2023
- TAX-MID 17K General Practice
- RX-LIGHT 401
- BOOK-THIN 158 in Massachusetts
- PHOTO-ENUM Megan Musilli, MD · 2023
Jasira Ziglar, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
401 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Jasira Ziglar, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jasira Ziglar, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How General Practice Physician compares to other specialties among Massachusetts providers
General Practice Physician ranks #115 among Massachusetts's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is General Practice Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for General Practice Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1952003030 |
|---|---|
| Specialty | General Practice Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/21/2023 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jasira Ziglar, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1952003030 is the unique 10-digit identifier CMS uses to link Ziglar across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Jasira Ziglar, MD. To verify Jasira Ziglar, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 65% generic, on 401 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 698.433
- Total Day Supply
- 19,879
- Brand vs Generic
- 30% brand / 65% generic
- Brand Drug Cost
- $81K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 66.5 years
- Avg HCC Risk Score
- 1.89
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 23, 65-74: 12, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jasira Ziglar, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
39 claims
- Trulicity
Trulicity
31 claims
- Metformin Hcl Er
Metformin Hcl Er
16 claims
- Farxiga 15
Farxiga
15 claims
- Lisinopril 14
Lisinopril
14 claims
- Famotidine 13
Famotidine
13 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 39 |
| Trulicity Dulaglutide | 31 |
| Metformin Hcl Er Metformin Hcl | 16 |
| Farxiga Dapagliflozin Propanediol | 15 |
| Lisinopril | 14 |
| Famotidine | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
General Practice Physician Overview
How Jasira Ziglar, MD fits within the General Practice Physician landscape nationally.
Jasira Ziglar, MD's 401 claims are below the specialty average of 2,957.
Nationwide General Practice Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ziglar, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2023)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby General Practice Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Ziglar.
One of 158 General Practice Physician providers enrolled in Massachusetts, 5 are shown here.
Compare General Practice Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jasira Ziglar, MD's specialty? ▼
How much does Jasira Ziglar, MD prescribe under Medicare Part D? ▼
Where is Jasira Ziglar, MD located? ▼
What is Jasira Ziglar, MD's NPI number? ▼
Does Jasira Ziglar, MD prescribe more brand-name or generic drugs? ▼
How many General Practice Physician providers are there in the US? ▼
What drugs does Jasira Ziglar, MD prescribe most often? ▼
Does Jasira Ziglar, MD accept Medicare? ▼
How can I verify Jasira Ziglar, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.